E-MAIL: [email protected]
USP〈1060〉 MASS SPECTROMETRY-BASED MULTI-ATTRIBUTE METHOD FOR THERAPEUTIC PROTEINS
012024.04
FDA approves first interchangeable biosimilars to Prolia and Xgeva to treat certain types of osteoporosis and prevent bone ev...
292024.03
AAV ophthalmic gene drug packaging-COP
272024.03
What aspects does the dissolution test of oral liquid bottles include
Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights
Reserved Powered by
MAKE AN ENQUIRY
